Shiferman Gregory L. 4
4 · Sage Therapeutics, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2025-01-16+28,000→ 28,000 totalExercise: $6.97Exp: 2035-01-16→ Common Stock (28,000 underlying) - Award
Common Stock
2025-01-16+14,000→ 33,888 total
Footnotes (2)
- [F1]Consists of shares of common stock issuable under 14,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.
- [F2]The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 7,000 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 21,000 shares vesting in 36 equal monthly installments thereafter.